Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.

Cupisti K, Wolf A, Raffel A, Schott M, Miersch D, Yang Q, Eisenberger CF, Röher HD, Knoefel WT.

Ann Surg. 2007 Nov;246(5):815-21.

PMID:
17968174
2.

Prognostic variables and calcitonin in medullary thyroid cancer.

Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL.

Laryngoscope. 2005 Aug;115(8):1445-50.

PMID:
16094121
3.

Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.

Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA Jr.

J Pediatr Surg. 1996 Jan;31(1):177-81; discussion 181-2.

PMID:
8632274
4.

Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.

Heizmann O, Haecker FM, Zumsteg U, Müller B, Oberholzer M, Oertli D.

Eur J Surg Oncol. 2006 Feb;32(1):98-102. Epub 2005 Dec 1.

PMID:
16325365
5.

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.

Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH.

Cancer. 2000 Mar 1;88(5):1139-48.

PMID:
10699905
6.

Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.

Skinner MA, Wells SA Jr.

Semin Pediatr Surg. 1997 Aug;6(3):134-40. Review.

PMID:
9263335
7.

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.

Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, Schlumberger M, Bigorgne JC, Dumontier P, Leclerc L, Corcuff B, Guilhem I.

Clin Endocrinol (Oxf). 1998 Mar;48(3):265-73.

PMID:
9578814
8.

Long-term prognosis of medullary thyroid carcinoma.

Rendl G, Manzl M, Hitzl W, Sungler P, Pirich C.

Clin Endocrinol (Oxf). 2008 Sep;69(3):497-505. doi: 10.1111/j.1365-2265.2008.03229.x. Epub 2008 Mar 10.

PMID:
18331612
9.

Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.

Gimm O, Ukkat J, Dralle H.

World J Surg. 1998 Jun;22(6):562-7; discussion 567-8.

PMID:
9597929
10.

Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.

Pomares FJ, Rodríguez JM, Nicolás F, Sola J, Canteras M, Balsalobre M, Pascual M, Parrilla P, Tébar FJ.

J Am Coll Surg. 2002 Nov;195(5):630-4.

PMID:
12437249
11.

Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.

Lupone G, Antonino A, Rosato A, Zenone P, Iervolino EM, Grillo M, De Palma M.

G Chir. 2012 Nov-Dec;33(11-12):395-9.

PMID:
23140924
12.

Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.

Pomorski L, Bartkowiak J, Pisarek H, Bartos M, Narebski J.

Neoplasma. 2000;47(5):323-6.

PMID:
11130252
13.

Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.

Franc S, Niccoli-Sire P, Cohen R, Bardet S, Maes B, Murat A, Krivitzky A, Modigliani E; French Medullary Study Group (GETC)..

Clin Endocrinol (Oxf). 2001 Sep;55(3):403-9.

PMID:
11589685
14.

Surgical management and follow-up of medullary thyroid carcinoma.

Marzano LA, Porcelli A, Biondi B, Lupoli G, Delrio P, Lombardi G, Zarrilli L.

J Surg Oncol. 1995 Jul;59(3):162-8.

PMID:
7609522
15.

Long term prognosis of medullary thyroid carcinoma in 39 patients.

Voutilainen PE, Multanen M, Haapiainen RK, Haglund CH, Sane T, Sivula AH.

Ann Chir Gynaecol. 2000;89(4):292-7.

PMID:
11204961
16.

Determinants of life expectancy in medullary thyroid cancer: age does not matter.

de Groot JW, Plukker JT, Wolffenbuttel BH, Wiggers T, Sluiter WJ, Links TP.

Clin Endocrinol (Oxf). 2006 Dec;65(6):729-36.

PMID:
17121523
17.

Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.

Pelizzo MR, Boschin IM, Bernante P, Toniato A, Piotto A, Pagetta C, Nibale O, Rampin L, Muzzio PC, Rubello D.

Eur J Surg Oncol. 2007 May;33(4):493-7. Epub 2006 Nov 27.

PMID:
17125960
18.

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.

Leboulleux S, Travagli JP, Caillou B, Laplanche A, Bidart JM, Schlumberger M, Baudin E.

Cancer. 2002 Jan 1;94(1):44-50.

19.

[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].

Murat A, Modigliani E, Conte-Devolx B, Rohmer V, Leclerc L, Guilhem I, Bigorgne JC, Boneu A, Maes B, Chabre O, Niccoli P, Schuffenecker I, Giraud S.

Ann Chir. 1998;52(5):455-60. French.

PMID:
9752487
20.

Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.

Peixoto Callejo I, Américo Brito J, Zagalo CM, Rosa Santos J.

Clin Transl Oncol. 2006 Jun;8(6):435-43.

PMID:
16790397

Supplemental Content

Support Center